An updated patent review of GPR40/ FFAR1 modulators (2020 - present)
{{output}}
Introduction: Free fatty acid receptor 1 (FFAR1) is a potential therapeutic target for type 2 diabetes mellitus (T2DM) because it could clinically stimulate insulin release in a glucose-dependent manner without inducing hypoglyce... ...